Dechra Pharmaceuticals Share Price (DPH)

1,419.50 -19.50 (-1.36%) delayed: 9:56PM GMT
Bid price 1,417.00 Open price 1,436.00
Ask price 1,422.00 Prev close 1,422.00
High price 1,440.00 Spread 0.35%
Low price 1,411.00 Volume 128,071

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,419.50 Net Gearing (%) 43.69
Market Capitalisation (£m) 1,339.02 Gross Gearing (%) 50.67
Shares in issue (m) 93.05 Debt Ratio 44.06
P/E Ratio 102.79 Debt-to-Equity Ratio 0.77
Total dividends per share (p) 18.46 Assets / Equity Ratio 2.03
Dividend Yield (%) 1.28 Price to book value 4.84
Dividend cover (x) 1.25 ROCE (%) 2.94
Earning per share (p) 14.00 EPS Growth (%) -36.77
52 week high / low 1,495.00 / 811.00 DPS Growth (%) 8.97

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
05/12/2016 BUY Tony Rice NED 120,000
30/11/2016 SELL Ian Page CEO 58,633
30/11/2016 SELL Tony Griffin ED 17,133
06/06/2016 BUY Tony Rice NED 20,000
18/03/2016 EXR Ian Page CEO 87,905

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

07:58 17/01/2017

Dechra revenues rise

Dechra Pharmaceuticals says reported group revenue for the six months to the end of December increased by approximately 34% at constant exchange rate (56% at actual exchange rate). Core group revenue growth, excluding the benefit from acquisitions, was 7% at CER (AER 22%); growth in the core...

07:02 17/01/2017

FLASH: Dechra revenues rise

Story provided by

07:00 17/01/2017

Trading Update

RNS Number : 3016U Dechra Pharmaceuticals PLC 17 January 2017   Tuesday, 17 January 2017     Dechra® Pharmaceuticals PLC ("Dechra" or "the Company ")    Trading Update     The Board of Dechra issues the following unaudited Trading Update...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p and...

Register now for FREE Dechra Pharmaceuticals share price discussions